Following news of job cuts in European R&D ops, Sanofi confirms it’s offering US workers an 'early exit'
Earlier in the week we learned that Sanofi was bringing out the budget ax to trim 466 R&D jobs in Europe, retooling its approach to cardio as research chief John Reed beefed up their work in cancer and gene therapies. And we’re ending the week with news that the pharma giant has also been quietly reducing staff in the US, targeting hundreds of jobs as the company pushes voluntary buyouts with a focus on R&D support services.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.